Drug Information Association (DIA) Canada Annual Meeting 2026

Drug Information Association (DIA) Canada Annual Meeting 2026 is organized by Drug Information Association (DIA) and will be held from Oct 26 - 27, 2026 at Hilton Lac-Leamy, Gatineau, Quebec, Canada.

Description:
The DIA Canada Annual Meeting will provide an in-depth exploration of the current pharmaceutical, medical device, and diagnostic landscapes in Canada, emphasizing Canada’s pivotal role in global healthcare product development. Offering three specialized tracks on Regulatory, Clinical, and Safety and Pharmacovigilance, the meeting will cover topics spanning from Health Canada’s latest regulatory initiatives, international collaboration, and innovative clinical practices to approaches that harness AI in drug safety and increase representation from equity-denied groups.

Learning Objectives:
At the conclusion of this activity, participants should be able to:

• Evaluate Health Canada's latest regulatory modernization initiatives and their implications for healthcare product development.
• Apply practical strategies for implementing AI responsibly across regulatory affairs, clinical development, and pharmacovigilance.
• Interpret emerging Canadian and international regulatory expectations, including ICH E6(R3), E8(R1), M15, and evolving M14 principles.
• Integrate digital technologies, structured data, and real-world evidence into regulatory and clinical decision-making.
• Strengthen inspection readiness, pharmacovigilance systems, and vendor oversight through risk-based approaches.
• Develop strategies that leverage regulatory reliance, harmonization, and international collaboration to accelerate patient access.
• Build cross-functional approaches that improve submission quality, clinical operations, and lifecycle regulatory management.
• Translate regulatory policy into practical implementation using real-world case studies and lessons learned.